About 70% of all invasive breast cancers express the estrogen receptor, making it of utmost importance to create more effective treatments, reduce resistance to current treatments, and improve outcomes through lifestyle interventions for these patients. The gene discussed is ESR1; the disease is invasive breast carcinoma.